Hunan Warrant Pharmaceutical Co (SHSE:688799) Total Equity: ¥2,076 Mil (As of Mar. 2026)


SHSE:688799 Hunan Warrant Pharmaceutical Co Ltd SHSE:688799
75 GF Score
Price ¥53.10
GF Value ¥33.23
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Hunan Warrant Pharmaceutical Co Total Equity?

Hunan Warrant Pharmaceutical Co SHSE:688799 +6.48% 75 Total Equity is ¥2,076 Mil as of Mar. 2026. GuruFocus rates SHSE:688799 with a GF Score™ of 75/100 and a GF Value™ of ¥33.23 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Hunan Warrant Pharmaceutical Co's total equity for the quarter that ended in Mar. 2026 was ¥2,076 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Hunan Warrant Pharmaceutical Co Total Equity Historical Data

* Premium members only.

The historical data trend for Hunan Warrant Pharmaceutical Co's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hunan Warrant Pharmaceutical Co Total Equity Chart

Hunan Warrant Pharmaceutical Co Annual Data
Trend Dec15 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,479.47 1,658.62 1,768.24 1,822.58 2,042.69

Hunan Warrant Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,874.74 1,858.15 1,992.12 2,042.69 2,075.83
SHSE:688799
75GF Score
Hunan Warrant Pharmaceutical Co Ltd SHSE:688799
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hunan Warrant Pharmaceutical Co Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Hunan Warrant Pharmaceutical Co's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=3053.643-1010.959
=2,043

Hunan Warrant Pharmaceutical Co's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=3240.175-1164.344
=2,076

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of ¥2,076 Mil mean?
Hunan Warrant Pharmaceutical Co (SHSE:688799) has a Total Equity of ¥2,076 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Hunan Warrant Pharmaceutical Co and its competitors.
Is Hunan Warrant Pharmaceutical Co's Total Equity too high?
Hunan Warrant Pharmaceutical Co's current Total Equity is ¥2,076 Mil. Overall, Hunan Warrant Pharmaceutical Co has a GF Score™ of 75/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hunan Warrant Pharmaceutical Co's Total Equity compare to ZTS and UTHR?
Hunan Warrant Pharmaceutical Co's Total Equity of ¥2,076 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Drug Manufacturers company?
A good Total Equity depends on the Drug Manufacturers industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Hunan Warrant Pharmaceutical Co and its competitors. Hunan Warrant Pharmaceutical Co's current Total Equity is ¥2,076 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hunan Warrant Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Hunan Warrant Pharmaceutical Co (SHSE:688799) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥33.23, compared to a current price of ¥53.10 — trading 59.8% above its estimated fair value. The current Total Equity is ¥2,076 Mil. Hunan Warrant Pharmaceutical Co's overall GF Score™ is 75/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Hunan Warrant Pharmaceutical Co (SHSE:688799), the current Total Equity is ¥2,076 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hunan Warrant Pharmaceutical Co (SHSE:688799) Overvalued in 2026?

Based on GuruFocus' analysis, Hunan Warrant Pharmaceutical Co stock appears to be overvalued. The current stock price of ¥53.10 is trading 59.8% above its estimated GF Value™ of ¥33.23. GuruFocus considers Hunan Warrant Pharmaceutical Co to be Significantly Overvalued.

Key valuation signals for SHSE:688799:

  • Total Equity: ¥2,076 Mil
  • GF Value™: ¥33.23 vs. price of ¥53.10 (59.8% above fair value)
  • GF Score™: 75/100 with 7 warning signs

No single metric tells the full story. See the SHSE:688799 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hunan Warrant Pharmaceutical Co Business Description

Address No. 28 Lutian Road, Building C6-C7, Yuelu District, Changsha, CHN, 410006
Hunan Warrant Pharmaceutical Co Ltd is a pharmaceutical manufacturer. It is engaged in the research and development, production and sales of chemical raw materials, chemical medicine preparations and Chinese medicine preparations.
75GF Score

Get the complete analysis for SHSE:688799

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥53.10
Price
¥33.23
GF Value